NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Cardiovascular Medicine

You are here: Home > Research Overview > Cardiovascular Medicine > OxVasc: Oxford Vascular Study

OxVasc: Oxford Vascular Study

The Oxford Vascular Study (OxVasc) provides reliable and up-to-date information on the incidence, causes and outcome of all acute vascular events, such as strokes and heart attacks, in a population of nearly 100,000 people living in Oxfordshire. OxVasc started in 2002 and is the first and only population-based study of all acute vascular events irrespective of age in the world. The overall aim of the study is to improve our understanding of these conditions, and how to better treat patients.

By collecting information from participants with vascular disease over a long period of time, we can track how the need for healthcare is changing, both for individuals and the population as a whole. For example, information gathered is used to answer questions such as:

  • How many people are having a stroke or heart attack? Is the number rising or falling with time and why?
  • Can we prevent acute vascular events with existing preventative strategies such as screening and risk factor management?
  • Are there any biomarkers or genes that would identify people at greater risk of vascular disease?

Participants must be registered with one of the following eight collaborating GP practices to join the study, and healthy “controls” are also recruited from the same population for comparison:

  • 19 Beaumont Street, Oxford
  • Bartlemas Surgery, Oxford
  • KEY Medical Practice, Kidlington and Yarnton
  • The Malthouse Surgery, Abingdon
  • Marcham Road Family Health Centre, Abingdon
  • The Abingdon Surgery, 65 Stert Street, Abingdon
  • Berinsfield Health Centre, Berinsfield
  • Church Street Practice, Wantage

The results already obtained from the OxVasc cohort have changed guidelines around the world on how patients with TIA (mini-strokes) are investigated and treated. For example, having shown that the risk of major stroke in the next few days is very high, that those individuals at highest risk can be identified using a simple risk score, and that emergency treatment reduces this early risk of major stroke (see below).

OxVasc

Other projects include detailed analyses of the incidence and outcome of acute coronary events, the first ever population-based study of the incidence and outcome of acute peripheral vascular events, and several studies of patient behaviour and the effectiveness of existing secondary prevention e.g. blood pressure lowering treatment.

For more information on OxVasc visit www.ndcn.ox.ac.uk/research/oxvasc

Cardiovascular Medicine

  • Cardiovascular Medicine
  • Sub-theme 1: Identifying and validating new therapeutic targets
  • Sub-theme 2: Applying new technologies to improve personalised prevention and management of CVD
  • Sub-theme 3: Addressing maternal cardiovascular risk
  • NIHR–British Heart Foundation Cardiovascular Partnership
    • NIHR-BHF collaborative projects
    • NIHR-BHF highlights
    • NIHR-BHF news and events
  • OxVasc: Oxford Vascular Study
  • OxVALVE: Oxford Valve Study
  • Contacts
  • Videos
  • PPI Case Study
  • News

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre